Compare Bristol-Myers Squibb Co (BMY) vs Motorola Solutions Inc (MSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs Motorola Solutions Inc — how do they compare? Bristol-Myers Squibb Co trades at $59.01 (market cap $116.30B), while Motorola Solutions Inc trades at $410.63 (market cap $68.67B). The key difference: Bristol-Myers Squibb Co is the larger of the two by market cap, and Bristol-Myers Squibb Co pays the higher dividend (4.42%). Which is the better fit depends on your goals.
| BMY | MSI | |
|---|---|---|
Market Cap | $116.30B | $68.67B |
Sector | Health | Technology |
52-Week High | $62.37 | $490.30 |
52-Week Low | $42.60 | $363.83 |
Enterprise Value | $152.24B | $77.38B |
Dividend Yield | 4.42% | 1.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bristol Myers Squibb (BMY) trades at $59.34, up 3.06% today, with a bullish technical signal and consistent earnings beats. The stock shows strong profitability with a 15.01% net margin and 38.84% ROE, though debt levels have risen. Recent FDA acceptance for mezigdomide in multiple myeloma highlights pipeline progress. Analysts are mixed with a $60 consensus target, slightly above current price.
BMY offers value with a P/E of 16.62 and a safe 4.3% dividend yield, but faces patent cliff risks and pricing pressures. Earnings growth and pipeline execution are key catalysts, while high debt and competitive threats require monitoring. The stock presents a balanced opportunity for income-focused investors with moderate risk tolerance.
Motorola Solutions (MSI) trades at $418.06, down 1.14% today, with a neutral technical signal despite recent earnings beats. The company shows strong fundamentals with 2025 revenue of $11.68B and net income of $2.15B, supported by a 99.88% ROE. Recent developments include the $1.5B D-Fend acquisition and AI expansion for emergency response systems, positioning MSI for growth in public safety technology.
MSI presents a compelling investment case with analyst consensus price target of $512.33 (22.5% upside) and 71% buy ratings. Strong profitability and strategic AI investments are offset by high valuation multiples (P/E 33.71) and negative cash flow from significant acquisitions. Key risks include integration challenges from recent deals and competitive pressure in the public safety sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About Motorola Solutions Inc
Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →
